In this Analysis, we searched for relevant literature on the effects of GLP-1RAs across a range of illnesses, gathering and describing the available pre-clinical and mechanistic (278 studies) and clinical (96 studies) evidence for cognitive disorders, substance-use disorders, psychotic disorders, mood and anxiety disorders, eating disorders, and others
Increase calories and consult your healthcare provider
Diabetes, Obesity & Metabolism, 23(3), 754762
Once-weekly mazdutide in Chinese adults with obesity or overweight
Can I File a Lawsuit for Health Problems Related to GLP-1 Drugs
The July 2026 nuance is that PlushCare has expanded into limited compounded semaglutide access in certain states during shortage periods